Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?

11:20am, Thursday, 10'th Mar 2022 Zacks Investment Research
Smart Beta ETF report for RYH
ST. LOUIS, March 9, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its Indiana subsidiary, Managed Health Services (MHS), has been selected by the Indiana Department of Administration to continue serving Hoosier Healthwise and Healthy Indiana Plan members with…

Centene Corporation – Consensus Indicates Potential 10.8% Upside

01:22pm, Tuesday, 08'th Mar 2022 DirectorsTalk
Centene Corporation found using ticker (CNC) now have 18 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 109 and 82 with a mean TP of 95.33. Now with the previous closing price of 86.05 this indicates there is a potential upside of 10.8%. There is a 50 day moving average of 81.15 and the 200 day moving average is 72.69. The market capitalisation for the company is $48,663m. You can visit the company''s website by visiting: https://www.centene.com [stock_market_widget type="chart" template="basic" color="green" assets=CNC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $53,912m based on the market concensus. Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programsluding Medicaid, the State children''s health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.

Centene Corporation – Consensus Indicates Potential 14.1% Upside

12:20pm, Tuesday, 01'st Mar 2022 DirectorsTalk
Centene Corporation with ticker code (CNC) now have 18 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 109 and 82 calculating the mean target price we have 95.33. With the stocks previous close at 83.52 this indicates there is a potential upside of 14.1%. There is a 50 day moving average of 81.02 and the 200 moving average now moves to 72.33. The market capitalisation for the company is $48,156m. Find out more information at: https://www.centene.com [stock_market_widget type="chart" template="basic" color="green" assets=CNC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $54,966m based on the market concensus. Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children''s health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.

Should Value Investors Consider Centene (CNC) Stock Now?

02:35pm, Monday, 28'th Feb 2022 Zacks Investment Research
Let's see if Centene Corporation (CNC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Let's see if Centene Corporation (CNC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

Select Medical (SEM) Q4 Earnings Beat on Higher Admissions

04:25pm, Friday, 25'th Feb 2022 Zacks Investment Research
Select Medical's (SEM) fourth-quarter results reflect solid revenues driven by robust contributions from all its segments, partly offset by higher costs and expenses.

Centene CEO Michael Neidorff takes medical leave

05:52pm, Thursday, 24'th Feb 2022
Centene Corp said on Thursday its board had approved a request from its chairman and chief executive officer Michael Neidorff for a period of medical leave, effective immediately.
Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, recently disclosed the firm's 13F portfolio changes for the fourth quarter of 2021, which ended on Dec. 31.
The campaign against the relentless tide of NHS privatisation will continue, despite a judicial review dismissing the campaigners'' case that there was a lack of patient consultation when GP practices in London were taken over by US health insurance giant Centene Corporation. Campaigners had argued at the High Court that there had been a lack of consultation… The post Unite Vows to Keep Fighting NHS Privatisation as Judge Dismisses ''Lack of Consultation'' on U.S. Takeover of London GPs appeared first on InsuranceNewsNet .
"Risk Factors" of this Form 10- K. The following discussion and analysis does not include certain items related to the year ended December 31, 2019, including year-to-year comparisons between the year ended December 31, 2020 and the year ended December 31, 2019. For a comparison of our results of operations for the fiscal years ended December 31, 2020 and The post CENTENE CORP 10-K Management''s Discussion and Analysis of Financial Condition and Results of Operations appeared first on InsuranceNewsNet .

Teladoc (TDOC) Unveils Solution to Ease Whole-Person Care

02:53pm, Monday, 21'st Feb 2022 Zacks Investment Research
Teladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members.

Humana (HUM) to Support Eligible Medicaid Members in Louisiana

08:05pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Humana (HUM) is picked by the Louisiana Department of Health for a contract win to help serve the Medicaid members in Louisiana.

Centene (CNC) Boosts Presence in Louisiana With Contract Win

05:05pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Centene's (CNC) latest contract renewal tends to improve health outcomes of Medicaid members of Louisiana.

Centene Corporation – Consensus Indicates Potential 15.4% Upside

02:51pm, Tuesday, 15'th Feb 2022 DirectorsTalk
Centene Corporation found using ticker (CNC) now have 19 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 111 and 82 and has a mean target at 96.16. Given that the stocks previous close was at 83.32 this would imply there is a potential upside of 15.4%. The 50 day moving average now sits at 79.88 and the 200 day moving average is 71.7. The market capitalisation for the company is $47,769m. You can visit the company''s website by visiting: https://www.centene.com [stock_market_widget type="chart" symbol="CNC" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $55,131m based on the market concensus. Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children''s health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE